Jazz Pharmaceuticals Announces Participation at Cowen 41st Annual Healthcare Conference

On February 23, 2021 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that the company will webcast its corporate presentation at the Cowen 41st Annual Healthcare conference (Press release, Jazz Pharmaceuticals, FEB 23, 2021, https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-participation-at-cowen-41st-annual-healthcare-conference-301232868.html [SID1234575493]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update on Tuesday, March 2, 2021, at 12:50 p.m. EST / 5:50 p.m. GMT.

A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of each presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archive of each webcast will be available for at least one week following each presentation on the Investors section of the company’s website at www.jazzpharmaceuticals.com.